Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-11-04

FDA Approved: ALISKIREN — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

FDA approved a supplemental application for Aliskiren hemifumarate submitted by Prasco Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aliskiren Hemifumarate (Aliskiren hemifumarate)

Snippet

SUPPL AP for ALISKIREN (ALISKIREN HEMIFUMARATE)